US & EU Patent Allowances for CBD Soft-Gel Formulation
Avecho has announced that both the United States Patent and Trademark Office (USPTO) and the European Patent Office (EPO) have allowed the Company’s patent applications relating to its proprietary cannabidiol (CBD) TPM ® soft-gel capsule, designed to enhance the absorption of CBD.
These allowances strengthen Avecho’s intellectual property position across two major global markets and extend protection for the formulation, including applications beyond CBD, through to at least 2040.
Avecho CEO, Dr Paul Gavin, said:
“Allowance of these applications in both Europe and the United States marks an important milestone for Avecho. It expands protection of our CBD TPM soft-gel capsule across two of the world’s largest pharmaceutical markets. As we progress our pivotal Phase III trial, these allowances strengthen the foundation for future regulatory submissions and commercial discussions, while further validating our leadership in cannabinoid formulation technology.”